Velocity-Based Resistance Training in Kidney Transplant Recipients (NCT07370727)
Effects of Velocity-Based Resistance Training on Renal Function and Metabolic Health in Kidney Transplant Recipients: Protocol for a Randomized Controlled Trial
🩺 Plain-English Summary (8th-Grade Level)
This randomized controlled trial aims to evaluate the effects of velocity-based resistance training on renal function and metabolic health in kidney transplant recipients. Participants will be randomized into two groups performing resistance training at different execution velocities (maximal intended vs. submaximal controlled). The intervention will last 12 weeks and include multi-joint exercises (squat, bench press, military press). Primary outcomes include renal function (serum creatinine, eGFR, blood urea nitrogen, uric acid) and metabolic markers (HDL, triglycerides, glucose, waist circumference, blood pressure). Secondary outcomes include muscle strength, force-velocity profile, anthropometry, physical activity, fitness perception, and adherence to immunosuppressive medication.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (5 items) and avoid the listed exclusions (7 items).
Location: Colombia — Bogotá, Bogota D.C.
Age range: 18 Years to 50 Years
🧪 Interventions in This Study
- Velocity-Based Resistance Training - Submaximal Velocity Protocol (OTHER)
- Velocity-Based Resistance Training - Maximal Velocity Protocol (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Active autoimmune disorders.
- Recent coronary disease (≤6 months).
- Severe musculoskeletal limitations incompatible with resistance training.
- Diagnosis of diabetes mellitus (pre- or post-transplant).
- Current active infection.
- Use of immunosuppressive drugs with contraindications for exercise (e.g., mTOR inhibitors at baseline).
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (1 Sites)
- Colombia — Bogotá, Bogota D.C.
📞 Contact the Study Coordinator
Phone: (312) 592-4821
Email: jpena69@areandina.edu.co
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Kidney Transplant Recipients
- Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant Recipients — Boston, Massachusetts
- The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients — Toronto, Ontario
Explore by condition: All Kidney Transplant Recipients clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.